Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dedrick

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy Reports|April 1, 1970
Interspecies correlation of plasma concentration history of methotrexate (NSC-740)R Dedrick, K B Bischoff, D S Zaharko
Journal of Endotoxin Research|November 3, 2005
Endotoxin: physical requirements for cell activationM Mueller, B Lindner, R Dedrick, et al.
Blood|May 1, 1994
Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing proteinK Mészáros, S Aberle, R Dedrick, et al.
Irish Journal of Medical Science|October 16, 2008
Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic diseaseG T O'Donoghue, G P Pidgeon, J H Harmey, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Heart (British Cardiac Society)|June 10, 2010
Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromesD P Chew, F A Anderson, A Avezum, et al.
Lupus|September 19, 2009
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosusM Petri, S Singh, H Tesfasyone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptidesY K Chou, W J Morrison, A D Weinberg, et al.
Journal of Neuroscience Research|February 1, 1994
T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosisY K Chou, A C Buenafe, R Dedrick, et al.
Journal of the American Academy of Dermatology|February 25, 2000
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasisA Gottlieb, J G Krueger, R Bright, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy Reports|April 1, 1970
Interspecies correlation of plasma concentration history of methotrexate (NSC-740)R Dedrick, K B Bischoff, D S Zaharko
Journal of Endotoxin Research|November 3, 2005
Endotoxin: physical requirements for cell activationM Mueller, B Lindner, R Dedrick, et al.
Blood|May 1, 1994
Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing proteinK Mészáros, S Aberle, R Dedrick, et al.
Irish Journal of Medical Science|October 16, 2008
Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic diseaseG T O'Donoghue, G P Pidgeon, J H Harmey, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Heart (British Cardiac Society)|June 10, 2010
Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromesD P Chew, F A Anderson, A Avezum, et al.
Lupus|September 19, 2009
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosusM Petri, S Singh, H Tesfasyone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptidesY K Chou, W J Morrison, A D Weinberg, et al.
Journal of Neuroscience Research|February 1, 1994
T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosisY K Chou, A C Buenafe, R Dedrick, et al.
Journal of the American Academy of Dermatology|February 25, 2000
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasisA Gottlieb, J G Krueger, R Bright, et al.
Pageof 1